Subscribe

Topic: National blog main

New with Topic: National blog main


Xconomy
Xconomy posted a blog entry
Under the Radar Deals: 10 (+1) New England October Financings You Never Heard About
The big picture is great. But at Xconomy, we also like the smaller details, which often fill in or round out the big...
 
Xconomy
Xconomy posted a blog entry
Ironwood Files to Go Public, Seeks to Raise as Much as $172.5M
Ironwood Pharmaceuticals is gearing up for the possibility of an IPO. The Cambridge, MA-based developer of a new treatment for...
 
Xconomy
Xconomy posted a blog entry
Google Demos Chrome OS, Microsoft Links Into LinkedIn, Amazon Ramps Up for Holidays, & More Big Company News
It’s been a busy week around here for the big tech companies. At Xconomy, we don’t usually report on things like...
 
Xconomy
Xconomy posted a blog entry
Day Software, Web 2.0 Content Management Specialist, Moving U.S. Headquarters to Boston
Wails of lamentation spread across the local tech community every time an entity like Zendesk or Greylock or Y Combinator...
 
Xconomy
Xconomy posted a blog entry
Biogen Idec Accused Again of Excessive CEO Pay, Lousy Performance, By Big Shareholder
[Update: 1:55 pm Eastern, 11/20/09] After a bitter standoff earlier this year with billionaire investor Carl Icahn over alleged...
 
Xconomy
Xconomy posted a blog entry
Mind, Body, & Cash: Lighter Living Raises $3M
Pilates is famous for shaping up peoples’ buttocks, tummies, and thighs. But what can the popularity of this fitness...
 
Xconomy
Xconomy posted a blog entry
After Re-Engineering Itself, Verdezyne Sets Course to Develop Biofuels and “Green” Industrial Chemicals
After Carlsbad, CA-based Verdezyne disclosed last month that it plans to raise more than $15 million in venture funding, I...
 
Xconomy
Xconomy posted a blog entry
RealSelf, Backed by Second Avenue and Rich Barton, Blazes Trail with Cosmetic Review Site
Who says consumer websites are dead? Maybe you don’t need the ridiculous traffic of, say, Seattle-based Cheezburger...
 
Xconomy
Xconomy posted a blog entry
Genzyme Halts Development of New Kidney Drug; A “Very Significant” Bust, Analyst Says
Another day, another piece of bad news from Genzyme. The Cambridge, MA-based biotech giant (NASDAQ: GENZ) said today it is...
 
Xconomy
Xconomy posted a blog entry
Steve Bratt, CEO of New World Wide Web Foundation, Details Plans To Make the Web More Usable in the Developing World
Only 25 percent of adults around the world have access to a computer that they can use to reach the Web. But 75 percent have...
 
Xconomy
Xconomy posted a blog entry
MyPunchbowl.com Acquires Group Travel Site I’m In, Transforms It Into Party Vendor Directory
Framingham, MA-based Punchbowl Software, the company behind party planning site MyPunchbowl.com, said today that it has...
 
Xconomy
Xconomy posted a blog entry
Paul Allen Diagnosed with Cancer
[Updated 11/16/09 6pm. See below] Microsoft co-founder and renowned technologist Paul Allen has been diagnosed with...
 
Xconomy
Xconomy posted a blog entry
Trubion CEO Peter Thompson Steps Down, Arch’s Gillis To Step Up Temporarily
[Updated: 5:55 pm Pacific, 11/16/09] Trubion Pharmaceuticals, the Seattle-based company developing new drugs for autoimmune...
 
Xconomy
Xconomy posted a blog entry
Rift Reported Between Founders and Board at Futuristic Carmaker Aptera
Paul Wilbur, a Detroit auto industry veteran who was named CEO of Carlsbad, CA-based Aptera 14 months ago, gave no indication...
 
Xconomy
Xconomy posted a blog entry
Global Analytics Raises $10M Amid Possible Deal
San Diego’s Global Analytics Holdings says it has raised $10 million of a targeted $14 million round that consists of...
 
Xconomy
Xconomy posted a blog entry
Fate Therapeutics Bags $30M Venture Deal, Led by OVP, to Develop “Industrialized” Stem Cells
Fate Therapeutics, the San Diego-based company on a quest to develop techniques that make stem cell research practical for the...
 
Xconomy
Xconomy posted a blog entry
ZoomAtlas—Helping You Reconnect With Friends from The Old Neighborhood
Say you’d like to look up an old friend from high school. You have no idea what happened to him after college, and you...
 
Xconomy
Xconomy posted a blog entry
Brightcove Debuts “Express” Video Hosting
To make it easier for small Web publishers to host videos on their sites, Cambridge, MA-based Brightcove will announce today...
 
Xconomy
Xconomy posted a blog entry
Avnera Raises $8M Equity Round to Advance Wireless Audio Chip Technology
A consumer tech company has scored one of the bigger equity financing rounds in the Portland area this fall. Beaverton,...
 
Xconomy
Xconomy posted a blog entry
Genzyme Shares Tank After FDA Discovers Bits of Steel, Rubber in Five Different Drugs
Just when you thought it couldn’t get worse for Genzyme, it did. The FDA reported today that it has found tiny bits of...
 
Xconomy
Xconomy posted a blog entry
Energy Networking Groups Merge
The Renewable Energy Business Network (REBN), a networking group for cleantech professionals with 10,000 members across 17...
 
Xconomy
Xconomy posted a blog entry
Seattle’s Bill McCoy, E-Books and Digital Distribution Expert, Leaving Adobe
We’ve all been wondering how the Adobe layoffs, reported earlier this week, may affect the Seattle area—especially...
 
Xconomy
Xconomy posted a blog entry
Enroute Closes Series A, Looks for More as It Expands and Aims for Profitability
Early-stage tech financings are still chugging along, it seems. On the heels of yesterday’s news of a $5.25 million financing...
 
Xconomy
Xconomy posted a blog entry
San Diego Serves as a Hotbed for Analytics Tech Cluster—at Least Up to a Point
When Tom Clancy introduced a panel discussion yesterday at a forum on analytics software, the founder of San Diego’s Tao...
 
Xconomy
Xconomy posted a blog entry
Dossia Off to Slow Start with Personal Electronic Health Records
Dossia is nearly three years from launching to provide electronic personal health records for major U.S. employers. And though...
 
Xconomy
Xconomy posted a blog entry
Trius Therapeutics Reveals Plans for IPO, SpectraScience Raises $4.3M, Sequenom Tightens its Belt, & More San Diego Life Sciences News
Some San Diego life sciences companies reported a burst of new financing, while embattled Sequenom told investors it’s trying...
 
Xconomy
Xconomy posted a blog entry
Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News
This was the week that a little biotech company in Bothell that few of the locals have ever heard of, burst onto the national...
 
Xconomy
Xconomy posted a blog entry
Isis Spinoff Altair Therapeutics Nails Down Extra $7M For Asthma Drug
San Diego-based Altair Therapeutics, a company developing inhalable drugs to block inflammatory proteins involved in asthma and...
 
Xconomy
Xconomy posted a blog entry
Boston’s Faneuil Hall Is a Finalist for Google Street View Visit—Vote Now, Then Meet Trike Builder Dan Ratner
Being journalists, we here at Xconomy try to refrain from bald political statements or endorsements. We’d never ask you...
 
Xconomy
Xconomy posted a blog entry
3Com Founder Bob Metcalfe Weighs in on News HP Has Purchased His Old Firm for $2.7 Billion
It was a newsroom holiday today at Xconomy, but Hewlett-Packard didn’t get the memo that we were off: the California company...
 
Xconomy
Xconomy posted a blog entry
Future of Search Event Nov. 30 to Draw Top Startups, VCs, and Execs to UW
Online search and information discovery are being transformed before our eyes. It’s no longer just Google, or Google and...
 
Xconomy
Xconomy posted a blog entry
Aileron’s New Class of Drugs Shown to Get Inside Cells to Block Prime Cancer Target
Cambridge, MA-based Aileron Therapeutics has bet the company on the idea that it has discovered a whole new class of drugs...
 
Xconomy
Xconomy posted a blog entry
As Wireless Data Traffic Surges, Qualcomm’s Lauer Outlines Efforts to Ease Network Bottlenecks
Qualcomm chief operating officer, Len Lauer, says the San Diego wireless chipmaking giant is working across a broad front of...
 
Xconomy
Xconomy posted a blog entry
Pulmatrix Pulls in $30.2M, GenArts Gobbles Up Wondertouch, BioVex Bags $30M, & More Boston-Area Deals News
Several of New England’s tech and life sciences firms got juicy deals the past week and a half.—Boston’s...
 
Xconomy
Xconomy posted a blog entry
Alder and New Partner, Bristol, to Give Amgen and Abbott a Run for Their Money
Alder Biopharmaceuticals keeps such a low profile that even after five years in business, few people in Seattle biotech know...
 
Xconomy
Xconomy posted a blog entry
Right Brains Wanted: Sanofi-Aventis Wants to Tap the Creative Genius of Boston-Area Biotechs
Sanofi-Aventis (NYSE: SNY) hosted a large event at its R&D site in Cambridge, MA, yesterday to make its pitch for why...
 
Xconomy
Xconomy posted a blog entry
Sequenom Looks to Prolong Operations as Available Cash Runs Low
San Diego’s embattled Sequenom, which halted the debut of a new diagnostic product over mishandled data, is now considering...
 
Xconomy
Xconomy posted a blog entry
Who Will Create the Future of San Diego Biotech? Xconomy Event Will Gather Star Innovators From Inside and Outside the Region
Who are the innovators who will help keep the San Diego region’s life sciences sector vibrant in the years to come? Which...
 
Xconomy
Xconomy posted a blog entry
Cambridge Public Library Grand Opening: A Beautiful Library for a Great Innovation City
When they write the book on great libraries of the world, a few legendary names will come to mind: Alexandria; Pergamum (the...
 
Xconomy
Xconomy posted a blog entry
BioVex Nails Down Another $30M To Finish Pivotal Study of Cancer-Killing Virus
BioVex, the Woburn, MA-based company aspiring to create the first FDA-approved cancer-killing virus, has raised an additional...
 
Xconomy
Xconomy posted a blog entry
Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer
Prostate cancer has been one of the hot fields for new biotech drug development this year, and now Cambridge, MA-based Tokai...
 
Xconomy
Xconomy posted a blog entry
Seattle’s Kineta Rakes in Half of $13M Federal Contract to UW For Vaccine Boosters
Kineta, the Seattle-based developer of drugs for autoimmune diseases, has won about half of a $13 million federal contract...
 
Xconomy
Xconomy posted a blog entry
Where Are the Software Deals? WA Firms Raised $70M in October, Mostly in Healthcare, Gaming
Early-stage software and IT deals are a scarce breed these days. That’s my initial take from looking at the October funding...
 
Xconomy
Xconomy posted a blog entry
Former Pfizer R&D Chief Joins PureTech Ventures as Senior Partner
PureTech Ventures says it has swelled its ranks with another Big Pharma veteran. John LaMattina, former president of global...
 
Xconomy
Xconomy posted a blog entry
San Diego’s Gizmo5 Reportedly Acquired by Google
San Diego’s Gizmo5, which was rumored to be a Skype acquisition target for $50 million about three weeks ago, is now reported...
 
Xconomy
Xconomy posted a blog entry
Good Things in Threes: Trius Therapeutics Files for IPO to Fund Phase 3 Clinical Trials, Marks San Diego’s Third IPO Filing
San Diego’s Trius Therapeutics, a venture-backed biotech developing a new antibiotic for treating acute and life-threatening...
 
Xconomy
Xconomy posted a blog entry
Clean Energy Week Preview: Of Green Ties and 52 Startups
We’ve noticed a slowing of venture investment in cleantech and other aspects of energy here in New England. But put any green...
 
Xconomy
Xconomy posted a blog entry
San Diego’s PaxVax Developing Oral Tablet Vaccine, Looks to Raise More Cash With Support of Seattle’s Ignition Capital
PaxVax, a San Diego startup backed by Seattle’s Ignition Capital, has raised $2 million of a planned $6 million investment...
 
Xconomy
Xconomy posted a blog entry
Concert Starts HIV Trial, Bags $12M From Glaxo to Help Challenge Gilead’s Once-Daily Pill
Concert Pharmaceuticals, the Lexington, MA-based company that chemically modifies existing drugs to make them more attractive,...
 
Xconomy
Xconomy posted a blog entry
Viridity Points to Greener, and Cheaper, Data Centers
Any company that owns or manages a data center, even a small one, knows how power-hungry they can be. It’s not unusual...